Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia

    ... in patients with World Health Organization-defined myelodysplastic syndromes , or acute myeloid leukemia with 20-30% bone marrow ...

    Research Article last updated 05/22/2014 - 9:28am.

  2. Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 07/18/2017 - 12:51pm.

  3. Self-reported sleep disturbance and survival in myelodysplastic syndromes

    ... survival (OS) are well understood for patients with myelodysplastic syndromes (MDS). New patients at our institution (n = 251; 2006-2014) ...

    Research Article last updated 03/22/2017 - 10:04am.

  4. Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes

    ... The myelodysplastic syndromes (MDS), a very complex heterogeneous myeloid disorder that ...

    Research Article last updated 03/03/2015 - 12:40pm.

  5. Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents

    ... Most anemic patients with non-deleted 5q lower-risk myelodysplastic syndromes (MDS) are treated with erythropoiesis-stimulating agents (ESAs), ...

    Research Article last updated 04/14/2017 - 9:09am.

  6. Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?

    ... Iron overload (IOL) portends inferior outcome in myelodysplastic syndromes (MDS). Erythropoiesis-stimulating agents (ESA) may reduce ...

    Research Article last updated 12/09/2015 - 8:52am.

  7. Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.

    ... The pathological hallmark of myelodysplastic syndromes (MDS) is marrow dysplasia, which represents the basis of the WHO ...

    Research Article last updated 03/22/2017 - 9:18am.

  8. The Myelodysplastic Syndromes: The Era Of Understanding

    ... Myelodysplastic syndromes are a heterogeneous group of clonal haematological stem cell ...

    Research Article last updated 09/24/2014 - 11:05am.

  9. Deacetylase Inhibitors for the Treatment of Myelodysplastic Syndromes

    ... Abstract Myelodysplastic syndromes (MDS) are a diverse group of myeloid disorders, with patients ...

    Research Article last updated 08/04/2014 - 8:31am.

  10. Quality of life varies by diagnosis for MDS patients

    ... health-related quality of life (HRQOL) in patients with myelodysplastic syndromes (MDS) may differ based on disease risk at diagnosis, according to ...

    Article last updated 12/13/2017 - 12:25pm.